Browsing by Author Bill Walsh Cancer Research Laboratories

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
PreviewIssue DateTitleAuthor(s)
19-Feb-2008A 39 kDa fragment of endogenous ASK1 suggests specific cleavage not degradation by the proteasomeStordal, Britta; Davey, Ross; Bill Walsh Cancer Research Laboratories
25-Jun-2008ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repairStordal, Britta; Davey, Ross; Bill Walsh Cancer Research Laboratories
2007Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic reviewStordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories
2006Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cellsStordal, Britta K; Davey, Mary W; Davey, Ross; Bill Walsh Cancer Research Laboratories
2009Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrestStordal, Britta; Davey, Ross; Bill Walsh Cancer Research Laboratories
2007A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationshipStordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories
2009Treating cisplatin-resistant cancer: a systematic analysis of oxaliplatin or paclitaxel salvage chemotherapy.Stordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories
2007Understanding cisplatin resistance using cellular modelsStordal, Britta; Davey, Mary W; Bill Walsh Cancer Research Laboratories